|
David A. Gay is a partner in the international law firm of McDermott Will & Emery LLP resident in the San Diego office. As a member of the Firm’s Intellectual Property, Media & Technology Department, David’s practice focuses on life sciences, biotechnology and all aspects of intellectual property law.
David advises established as well as emerging pharmaceutical and biotechnology companies as to the strategic design, creation, acquisition and management of intellectual property portfolios, with particular attention to the integration of business objectives and competitive technologies. David’s expertise includes evaluating patent portfolios and conducting due diligence for venture capital, private and public financing, as well as for mergers and acquisitions in the pharmaceutical and biotechnology areas.
David’s experience encompasses patent portfolio management, U.S. and foreign patent prosecution, opposition proceedings, due diligence reviews, freedom to operate investigations, validity and infringement analyses, and technology licensing. Having practiced in the biotechnology arena for nearly thirteen years, David brings to bear a broad-based expertise and frequently counsels clients addressing sophisticated issues in bioinformatics and related technologies merging life science and high technology concepts. In the area of strategic planning, David advises corporations on the management of portfolios in areas including protein and small molecule therapeutics, humanized antibodies, immunomodulatory agents, pharmaceutical formulations, genomics, proteomics, bioinformatics and biosensors as well as in diverse areas of biochemistry, genetics and molecular biology.
David received his Ph.D. in biochemistry from Johns Hopkins University School of Medicine and earned his J.D. from the University of San Diego School of Law. He is a member of the State Bar of California and the District of Columbia and is admitted to practice before the U.S. District Court for the Southern District of California. David is a registered patent attorney admitted to practice before the U.S. Patent and Trademark Office.
David is co-chair of the Special Committee on Biosciences and Chemical Practice for the ABA Section on Intellectual Property Law. Previously, David served as the co-chair for the Licensing Committee and as the chair of the Patent Licensing Subcommittee for the same ABA Section.
Education:
University of San Diego School of Law, J.D.
Johns Hopkins University School of Medicine, Ph.D.
University of Maryland, B.A. | 